CERK
CERK (ceramide kinase, also known as hCERK, LK4 and KIAA1646) is a lipid kinase that phosphorylates ceramide to form ceramide 1-phosphate (C1P), a sphingolipid metabolite. It belongs to the SPHK, AGK, CERK lipid kinase family. Browse Assay Genie's current range of CERK research reagents below, or read on for the biology behind the target.
CERK catalyses the specific phosphorylation of ceramide to give ceramide 1-phosphate (C1P). The enzyme acts efficiently on natural ceramides and on analogues including C6, C8 and C16 ceramides and C8-dihydroceramide. It is less active towards C2-ceramide and C6-dihydroceramide, and it does not act on other lipids such as the various sphingosines. It shows a greater preference for the D-erythro isomer of ceramides. CERK also binds phosphoinositides.
The human CERK gene encodes a protein classified by HGNC in the SPHK, AGK, CERK lipid kinase family. UniProt records the protein as localised to the cell membrane and the trans-Golgi network. The CERK protein is also referred to as hCERK, and the gene has appeared in the literature and databases under several identifiers, including FLJ23239, dA59H18.3, DKFZp434E0211, FLJ21430, KIAA1646, LK4 and dA59H18.2. A mouse ortholog, Cerk, is recognised.
Ceramide and C1P are both sphingolipid metabolites, and the CERK-catalysed step links them. According to the NCBI Gene summary, both CERK and C1P have been implicated in cellular processes including proliferation, apoptosis, phagocytosis and inflammation. This makes CERK a useful focus for researchers studying sphingolipid metabolism and the way lipid kinase activity shapes cell behaviour.
CERK converts ceramide to ceramide 1-phosphate, placing it at a defined step in sphingolipid metabolism.
CERK and C1P have been implicated in proliferation and apoptosis, making the enzyme relevant to studies of cell fate.
CERK and its product C1P have been linked to inflammation and phagocytosis, two processes studied in immune cell biology.
CERK is specific for ceramide, prefers the D-erythro isomer and binds phosphoinositides, which suits substrate selectivity studies.
CERK is a lipid kinase that catalyses the phosphorylation of ceramide to form ceramide 1-phosphate (C1P). It acts specifically on ceramides rather than on other lipids such as sphingosines, prefers the D-erythro isomer, and also binds phosphoinositides.
CERK stands for ceramide kinase. Aliases and earlier identifiers include hCERK, FLJ23239, dA59H18.3, DKFZp434E0211, FLJ21430, KIAA1646, LK4 and dA59H18.2. Its enzyme classification is EC 2.7.1.138, and HGNC places it in the SPHK, AGK, CERK lipid kinase family.
A mouse ortholog, Cerk, is recognised, so rodent models can be used to study the gene; check the datasheet of any product for its validated reactivity. The NCBI summary links CERK and C1P to proliferation, apoptosis, phagocytosis and inflammation.
Other lipid kinases and sphingolipid-metabolism targets that may be of interest alongside CERK.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8TCT0; product specifications from Assay Genie datasheets.